Clinical Trials Directory

Trials / Completed

CompletedNCT04525105

SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE

ARE SMAD2, SMAD3 AND TGF-β GENE EXPRESSION VALUABLE IN THE MANAGEMENT OF THE URGE URINARY INCONTINENCE?

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Muğla Sıtkı Koçman University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Urge urinary incontinence (UUI) is a common health problem. Changes in collagen metabolism in pelvic support organs, such as uterosacral ligaments (USLs), might be responsible for the complex pathophysiology of UUI. The TGF-β pathway is involved in collagen synthesis and degradation. The Transforming Growth Family- β (TGF-β) superfamily has essential intracellular signaling components, such as newly identified SMAD family members. We evaluated the changes in the levels of TGF-β and SMAD gene and protein expression in the USL of patients with concomitant pelvic organ prolapse (POP) and UUI.

Detailed description

This study included 10 patients who had been diagnosed with POP and UUI in the study group and 14 asymptomatic women without complaints of POP and UUI in the control group. Biopsy samples were collected from bilateral USL tissues during vaginal or abdominal hysterectomy. Total RNA was extracted from USL tissue and analyzed by qPCR. The protein expression levels were also analyzed with ELISA.

Conditions

Interventions

TypeNameDescription
GENETICSMAD2a family of structurally related cytokines

Timeline

Start date
2017-11-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2020-08-25
Last updated
2020-08-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04525105. Inclusion in this directory is not an endorsement.